We are live on ! Find out more
GVAG

Great Valley Advisor Group Portfolio holdings

AUM $5.5B
1-Year Est. Return 20.56%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+20.56%
3 Year Est. Return
+61.82%
5 Year Est. Return
+67.54%
10 Year Est. Return
AUM
$1.79B
AUM Growth
-$33.8M
Cap. Flow
+$66.4M
Cap. Flow %
3.72%
Top 10 Hldgs %
19.04%
Holding
724
New
52
Increased
324
Reduced
249
Closed
51
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPS
651
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$78K ﹤0.01%
+11,867
New +$87.3K
AROC icon
652
Archrock
AROC
$6.33B
$69K ﹤0.01%
+10,820
New +$82.5K
CIM
653
Chimera Investment
CIM
$1.05B
$69K ﹤0.01%
+4,392
New +$114K
DHY
654
Credit Suisse High Yield Credit Fund
DHY
$238M
$61K ﹤0.01%
34,666
+828
+2% +$1.6K
BGY icon
655
BlackRock Enhanced International Dividend Trust
BGY
$512M
$59K ﹤0.01%
13,185
ELVN icon
656
Enliven Therapeutics
ELVN
$3.78B
$48K ﹤0.01%
5,253
CERS icon
657
Cerus
CERS
$587M
$43K ﹤0.01%
11,973
DHF
658
BNY Mellon High Yield Strategies Fund
DHF
$171M
$28K ﹤0.01%
13,498
+321
+2% +$741
PRPO icon
659
Precipio
PRPO
$42.3M
$27K ﹤0.01%
1,655
NOVN
660
DELISTED
Novan, Inc. Common Stock
NOVN
$20K ﹤0.01%
+10,726
New +$27K
MDNA
661
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$16K ﹤0.01%
19,500
PSTV icon
662
Plus Therapeutics
PSTV
$26.4M
$15K ﹤0.01%
90
ATIP
663
DELISTED
ATI Physical Therapy, Inc.
ATIP
$14K ﹤0.01%
281
TGB
664
Trekor Metals
TGB
$2.56B
$11K ﹤0.01%
10,000
OPGN
665
DELISTED
OpGen, Inc
OPGN
$7K ﹤0.01%
126
XBIO icon
666
Xenetic Biosciences
XBIO
$6.05M
$6K ﹤0.01%
1,060
NYMX
667
DELISTED
Nymox Pharmaceutical Corp
NYMX
$4K ﹤0.01%
10,000
CATX icon
668
Perspective Therapeutics
CATX
$332M
$3K ﹤0.01%
1,200
AAL icon
669
American Airlines Group
AAL
$9.58B
-10,991
Closed -$140K
AR icon
670
Antero Resources
AR
$10.9B
-12,408
Closed -$380K
ARKG icon
671
ARK Genomic Revolution ETF
ARKG
$1.51B
-12,013
Closed -$378K
ARKW icon
672
ARK Web x.0 ETF
ARKW
$1.64B
-4,206
Closed -$206K
AZN icon
673
AstraZeneca
AZN
$263B
-1,624
Closed -$215K
BABA icon
674
Alibaba
BABA
$269B
-2,610
Closed -$296K
BBY icon
675
Best Buy
BBY
$18B
-4,711
Closed -$307K

Similar funds

Great Valley Advisor Group's Q3 2022 Portfolio in Review

As of Q3 2022, Great Valley Advisor Group held 724 positions worth $1.79B, down 1.9% from $1.82B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Great Valley Advisor Group deployed $66.4M of net new capital in Q3 2022, opening 52 new positions and adding to 324 existing holdings. Its largest new stake was WisdomTree Emerging Markets SmallCap Dividend Fund: 275,024 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Invesco S&P Emerging Markets Low Volatility ETF, an estimated $14.2M trimmed.

  • Great Valley Advisor Group's largest Q3 2022 buy was WisdomTree Emerging Markets SmallCap Dividend Fund: 275,024 shares worth $11M.
  • Great Valley Advisor Group added most to State Street SPDR Portfolio Aggregate Bond ETF in Q3 2022, an estimated $24M increase.
  • Great Valley Advisor Group's biggest Q3 2022 reduction was Invesco S&P Emerging Markets Low Volatility ETF, cutting an estimated $14.2M.
  • Great Valley Advisor Group fully exited Invesco S&P 500 Pure Value ETF in Q3 2022, selling an estimated $11.4M.
  • Great Valley Advisor Group's ten largest holdings make up 19% of its $1.79B portfolio in Q3 2022.
  • Great Valley Advisor Group opened 52 new positions and closed 51 in Q3 2022.
  • Great Valley Advisor Group's portfolio value fell 1.9% quarter-over-quarter to $1.79B.

Based on Great Valley Advisor Group's 13F filing for Q3 2022, filed 21 Oct 2022.